High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality Scott GordonAnita DurairajW. Sean Davidson OriginalPaper 06 January 2010 Pages: 1 - 8
Metagenomics, Lipoproteins, and Cardiovascular Risk Erik Eckhardt OriginalPaper 31 December 2009 Pages: 9 - 14
Chronobiology: Influences on Metabolic Syndrome and Cardiovascular Risk Marta GarauletJuan Antonio Madrid OriginalPaper 23 January 2010 Pages: 15 - 23
Lipoxins, Resolvins, Protectins, Maresins, and Nitrolipids: Connecting Lipids, Inflammation, and Cardiovascular Disease Risk Undurti N. Das OriginalPaper 31 December 2009 Pages: 24 - 31
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk Giovanni Targher OriginalPaper 06 January 2010 Pages: 32 - 39
Vitamin D, Insulin Resistance, and Type 2 Diabetes Yiqing SongJoAnn E. Manson OriginalPaper 06 January 2010 Pages: 40 - 47
Vegetarian Dietary Patterns as a Means to Achieve Reduction in Cardiovascular Disease and Diabetes Risk Factors Amy Joy LanouBarbara Svenson OriginalPaper 24 December 2009 Pages: 48 - 56
Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Measurement of Inflammatory Risk: Independent or Complementary? Carlos Iribarren OriginalPaper 24 December 2009 Pages: 57 - 67
Vitamin D Deficiency and Its Implications on Cardiovascular Disease Nisha AggarwalJared P. ReisErin D. Michos OriginalPaper 07 January 2010 Pages: 68 - 75
Cardiovascular Disease Risk Factors in Blacks Living in the Caribbean Trevor FergusonMarshall Tulloch-Reid OriginalPaper 09 January 2010 Pages: 76 - 82